Mesoporous silica nanoparticles functionalized with folic acid for targeted release Cis-Pt to glioblastoma cells
Source abstract
Abstract
Abstract This work reports the preparation, characterization, and a drug release study of mesoporous silica nanoparticles (MNPSiO2) functionalized with folic acid (FA) and loaded with Cis-Pt as a targeted release system to kill glioblastoma cancer cells. The MNPSiO2 were synthesized by the Stöber method using hexadecyltrimethylammonium bromide as the templating agent, which was finally removed by calcination at 550°C. The folic acid was chemically anchored to the silica nanoparticles surface by a carbodiimide reaction. Several physicochemical techniques were used for the MNPSiO2 characterization, and a triplicate in vitro Cis-Pt release test was carried out. The release Cis-Pt experimental values were fitted to different theoretical models to find the Cis-Pt release mechanism. The cytotoxicity evaluation of the MNPSiO2 was performed using LN 18 cells (human GBM cells). Homogeneous and well-defined nanoparticles with well-distributed and homogeneous porosity were obtained. The spectroscopic results show the proper functionalization of the mesoporous nanoparticles; besides, MNPSiO2 showed high surface area and large pore size. High correlation coefficients were obtained. Though the best fitted was the Korsmeyer-Peppas kinetic model, the Higuchi model adjusted better to the results obtained for our system. The MNPSiO2-FA were highly biocompatible, and they increased the cytotoxic effect of Cis-Pt loaded in them.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanocluster Synthesis and Applications · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Nanotechnology Laboratory . National Institute of Neurology and Neurosurgery . Insurgentes Sur 3877, La Fama , México City , México
Nanotechnology Laboratory . National Institute of Neurology and Neurosurgery . Insurgentes Sur 3877, La Fama , México City , México ; Universidad Tecnológica del Centro de Veracruz . Av. Universidad No.350 , , Cuitláhuac , Veracruz , México
ESIQIE-National Polytechnic Institute . Instituto Politécnico Nacional s/n, Col. Zacatenco , México City , México
Neuroimmunoendocrinology Laboratory . National Institute of Neurology and Neurosurgery , Insurgentes sur 3877, Tlalpan , México City , Mexico
Metropolitan Autonomous University-Iztapalapa . Av. San Rafael Atlixco, Iztapalapa , , México
Universidad Tecnológica del Centro de Veracruz . Av. Universidad No.350 , , Cuitláhuac , Veracruz , México
References (45)
Show source-provided references
1. Tang, F., L. Li, and D. Chen. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Advanced materials, Vol. 24, No. 12, 2012, pp. 1504–1534.10.1002/adma.201104763 ↗
2. Asefa, T., and Z. Tao. Biocompatibility of mesoporous silica nanoparticles. Chemical Research in Toxicology, Vol. 25, No. 11, 2012, pp. 2265–2284.10.1021/tx300166u ↗
3. Thi, T., V.D. Cao, T.N.Q. Nguyen, D.T. Hoang, V.C. Ngo, and D.H. Nguyen. Functionalized mesoporous silica nanoparticles and biomedical applications. Materials Science & Engineering C, Vol. 99, 2019, pp. 631–656.10.1016/j.msec.2019.01.129 ↗
4. Wu, S.H., C.Y. Mou, and H.P. Lin. Synthesis of mesoporous silica nanoparticles. Chemical Society Reviews, Vol. 42, No. 9, 2013, pp. 3862–3875.10.1039/c3cs35405a ↗
5. Manzano, M., and M. Vallet-Regí. Mesoporous silica nanoparticles in nanomedicine applications. Journal of Materials Science: Materials in Medicine, Vol. 29, No. 5, 2018, pp. 1–14.10.1007/s10856-018-6069-x ↗
6. Shimura, N., and M. Ogawa. Preparation of surfactant templated nanoporous silica spherical particles by the Stöber method. Effect of solvent composition on the particle size. Journal of Materials Science, Vol. 42, No. 14, 2007, pp. 5299–5306.10.1007/s10853-007-1771-y ↗
7. Sayani, N., K. Debtosh, and N. Milan Kanti. Synthesis of meso-porous Stöber silica nanoparticles: the effect of secondary and tertiary alkanolamines. Journal of Sol-Gel Science and Technology, Vol. 72, 2014, pp. 49–55.10.1007/s10971-014-3420-7 ↗
8. Dement’eva, O.V., I.N. Senchikhin, M.E. Kartseva, V.A. Ogarev, A.V. Zaitseva, N.N. Matushkina, et al. A new method for loading mesoporous silica nanoparticles with drugs: sol-gel synthesis using drug micelles as a template. Colloid Journal, Vol. 78, 2016, pp. 586–595.10.1134/S1061933X16050045 ↗
9. Tripathy, S.K., A. Mishra, S.K. Jha, R. Wahab, and A.A. Al-Khedhairy. Microwave assisted hydrothermal synthesis of mesoporous SnO2 nanoparticles for ethanol sensing and degradation. Journal of Materials Science: Materials in Electronics, Vol. 24, 2013, pp. 2082–2090.10.1007/s10854-013-1062-0 ↗
10. Li, M., C. Zhang, X.L. Yang, and H.B. Xu. Microfluidization-assisted synthesis of hollow mesoporous silica nanoparticles. Journal of Sol-Gel Science and Technology, Vol. 67, No. 3, 2013, pp. 501–506.10.1007/s10971-013-3107-5 ↗
11. Xin, D., G. Lei, F. Yuqin, L. Dan, and L. Changli. Non-surfactant template-directed synthesis of SiO2-polyimide hybrid self-standing films with ordered mesoporous structure. Polymers for Advanced Technologies, Vol. 22, No. 12, 2011, pp. 2424–2429.10.1002/pat.1779 ↗
12. Wang, X., Y. Zhang, W. Luo, A.A. Elzatahry, X. Cheng, A. Alghamdi, et al. Synthesis of ordered mesoporous silica with tunable morphologies and pore sizes via a nonpolar solvent-assisted Stöber method. Chemistry of Materials, Vol. 28, No. 7, 2016, pp. 2356–2362.10.1021/acs.chemmater.6b00499 ↗
13. Li W., and D. Zhao. Extension of the Stöber method to construct mesoporous SiO2 and TiO2 shells for uniform multifunctional core-shell structures. Advanced Materials, Vol. 25, No. 1, 2013, pp. 142–149.10.1002/adma.201203547 ↗
14. Vivero-Escoto, J.L., I.I. Slowing, B.G. Trewyn, and V.S.-Y. Lin. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small, Vol. 6, No. 18, 2010, pp. 1952–1967.10.1002/smll.200901789 ↗
15. Jafari, S., H. Derakhshankhah, L. Alaei, A. Fattahi, B.S. Varnamkhasti, and A.A. Saboury. Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomedicine & Pharmacotherapy, Vol. 109, 2019, pp. 1100–1111.10.1016/j.biopha.2018.10.167 ↗
16. Wang, Y., Q. Zhao, N. Han, L. Bai, J. Li, J. Liu et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, No. 2, 2015, pp. 313–327.10.1016/j.nano.2014.09.014 ↗
17. Izquierdo-Barba, I., M. Colilla, and M. Vallet-Regil. Nanostructured mesoporous silicas for bone tissue regeneration. Journal of Nanomaterials, Vol. 2008, No. 2, 2008, pp.1–14.10.1155/2008/106970 ↗
18. Wang, Y., and H. Gu. Core-shell-type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery. Advanced Materials, Vol. 27, No. 3, 2015, pp. 576–585.10.1002/adma.201401124 ↗
19. Trewyn, B.G., I.I. Slowing, S. Giri, H-T. Chen, and V.S.-Y. Lin. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Accounts of Chemical Research, Vol. 40, No. 9, 2007, pp. 846–853.10.1021/ar600032u ↗
20. Feng, S., H. Zhang, S. Xu, C. Zhi, H. Nakanishi, and X-D. Gao. Folate-conjugated, mesoporous silica functionalized boron nitride nanospheres for targeted delivery of doxorubicin. Materials Science & Engineering C, Vol. 96, 2019, pp. 552–560.10.1016/j.msec.2018.11.063 ↗
21. Giret, S., M. Wong Chi Man, and C. Carcel. Mesoporous-silica-functionalized nanoparticles for drug delivery. Chemistry A European Journal, Vol. 21, No. 40, 2015, pp.13850–13865.10.1002/chem.201500578 ↗
22. Xiaodong, S., C. Lijue, L. Chengpeng, H. Canzhong, H. Li, and K. Lingxue. Functionalization of hollow mesoporous silica nanoparticles for improved 5-FU loading. Journal of Nanomaterials, Vol. 2015, 2015, pp. 1–9.10.1155/2015/872035 ↗
23. Sanna, V., N. Pala, and M. Sechi. Targeted therapy using nanotechnology: focus on cancer. International Journal of Nanomedicine, Vol. 9, No. 1, 2014, pp. 467–483.10.2147/IJN.S36654 ↗
24. Bertrand, N., J. Wu, X. Xu, N. Kamaly, and O.C. Farokhzad. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews, Vol. 66, 2014, pp. 2–25.10.1016/j.addr.2013.11.009 ↗
25. Samadian, H., S. Hosseini-Nami, S.K. Kamrava, H. Ghaznavi, and A. Shakeri-Zadeh. Folate-conjugated gold nanoparticles as a new nanoplatform for targeted cancer therapy. Journal of Cancer Research and Clinical Oncology, Vol. 142, No. 11, 2016, pp. 2217–2229.10.1007/s00432-016-2179-3 ↗
26. Melo-Diogo, D., R. Lima-Sousa, C.G. Alves, E.C. Costa, R.O. Louro, and I.J. Correia. Functionalization of graphene family nanomaterials for application in cancer therapy. Colloids and Surfaces B: Biointerfaces, Vol. 171, 2018, pp. 260–275.10.1016/j.colsurfb.2018.07.030 ↗
27. Kazerooni, A.F., S. Bakas, H.S. Rad, and C. Davatzikos. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review. International Society for Magnetic Resonance in Medicine, Vol. 52, No. 1, 2019, pp. 1–16.10.1002/jmri.26907 ↗
28. Dasari, S., and P.B. Tchounwou. Cisplatin in cancer therapy: molecular mechanisms of action. European Journal of Pharmacology, Vol. 740, 2014, pp. 364–378.10.1016/j.ejphar.2014.07.025 ↗
29. Go., R.S., and A.A. Adjei. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. Journal of Cancer Research and Clinical Oncology, Vol. 17, No. 1, 1999, pp. 409–422.10.1200/JCO.1999.17.1.409 ↗
30. Ghosh, S. Cisplatin: the first metal based anticancer drug. Bioorganic Chemistry, Vol. 88, 2019, pp. 1–20.10.1016/j.bioorg.2019.102925 ↗
31. Ortiz-Islas, E., M.E. Manríquez-Ramírez, A. Sosa-Muñoz, P. Almaguer, C. Arias, P. Guevara, et al. Preparation and characterization of silica-based nanoparticles for cisplatin release on cancer brain cells. IET Nanobiotechnology, Vol. 14, No. 3, 2020, pp. 191–197.10.1049/iet-nbt.2019.0239 ↗
32. Uribe-Robles, M., E. Ortiz-Islas, E. Rodriguez-Perez, T. Lim, and A.A. Martinez-Morales. TiO2 hollow nanospheres functionalized with folic acid and ZnPc for targeted photodynamic therapy in glioblastoma cancer MRS Communications, Vol. 9, 2019, pp. 1242–1248.10.1557/mrc.2019.142 ↗
33. Düzlü, A., B. Günaydın, M. Şüküroğlu, and İ. Değim. Release pattern of liposomal bupivacaine in artificial cerebrospinal fluid. Turkish Journal of Anaesthesiology and Reanimation, Vol. 44, 2016, pp. 1–6.10.5152/TJAR.2016.02438 ↗
34. Diserens, A., N. de Tribolet, A. Martin-Achard, A.C. Gaide, J.F. Schnegg, and S. Carrel. Characterization of an established human malignant glioma cell line: LN-18. Acta Neuropathologica, Vol. 53, No. 1, 1981, pp. 21–28.10.1007/BF00697180 ↗
35. Freshney, R.I. Subculture and cell lines. In culture of animal cells: A manual of basic technique and specialized applications, 7th edn, Freshney, R. I., Ed. Wiley-Blackwell Inc., 2016, pp. 235–258.
36. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, Vol. 65, No. 1-2, 1983, pp. 55–63.10.1016/0022-1759(83)90303-4 ↗
37. Fernandes-Cipreste, M., I. Gonzalez, T. Maria da Mata-Martins, A. Miranda-Goes, W. A. de Almeida-Macedo, and E. Martins Barros de Sousa. Attaching folic acid on hydroxyapatite nanorod surfaces: an investigation of the HA-FA interaction. RSC Advances, Vol. 6, No. 80, 2016, pp. 76390–76400.10.1039/C6RA14068H ↗
38. Qi, L., Y. Guo, J. Luan, D. Zhang, Z. Zhao, and Y. Luan. Folate-modified bexarotene-loaded bovine serum albumin nanoparticles as a promising tumortargeting delivery system. Journal of Materials Chemistry B, Vol. 2, 2014, pp. 8361–8371.10.1039/C4TB01102C ↗
39. Eskandari, P., Z. Abousalman-Rezvani, S. Hajebi, H. Roghani-Mamaqani, and M. Salami-Kalajahi. Controlled release of anti-cancer drug from the shell and hollow cavities of poly(N-isopropylacrylamide) hydrogel particles synthesized via reversible addition-fragmentation chain transfer polymerization. European Polymer Journal, Vol. 35, 2020, pp. 1–11.10.1016/j.eurpolymj.2020.109877 ↗
40. González Hurtado, M., J. Rieumont Briones, L.M. Castro González, E. Ortiz-Islas, and I. Zumeta-Dube. Kinetic studies of the release profiles of antiepileptic drug released from a nanostructured TiO2 matrix. Journal of Advances in Chemistry, Vol. 12, No. 4, 2016, pp. 4365–4373.10.24297/jac.v12i4.2176 ↗
41. Ata, S., A. Rasool, A. Islam, I. Bibi, M. Rizwan, M.K. Azeem, et al. Loading of cefixime to pH sensitive chitosan based hydrogel and investigation of controlled release kinetics. International Journal of Biological Macromolecules, Vol. 155, 2020, pp. 1236–1244.10.1016/j.ijbiomac.2019.11.091 ↗
42. Hajebi, S., A. Abdollahi, H. Roghani-Mamaqani, and M. Salami-Kalajahi. Temperature-responsive poly(N-Isopropylacrylamide) nanogels: The role of hollow cavities and different shell cross-linking densities on doxorubicin loading and release. Langmuir, Vol. 36, 2020, pp. 2683–2694.10.1021/acs.langmuir.9b03892 ↗
43. Zhou, T., X. Zhao, L. Liu, and P. Liu. Preparation of biodegradable PEGylated pH/reduction dual-stimuli responsive nanohydrogels for controlled release of an anti-cancer drug. Nanoscale, Vol. 7, No. 28, 2015, pp. 12051–12060.10.1039/C5NR00758E ↗
44. Bohrey, S., V. Chourasiya, and A. Pandey. Polymeric nanoparticles containing diazepam: preparation, optimization, characterization, in-vitro drug release and release kinetic study. Nano Convergence, Vol. 3, No. 3, 2016, pp. 1–7.10.1186/s40580-016-0061-2 ↗
45. Souza, K.C., J.D. Ardisson, and E.M.B. Sousa. Study of mesoporous silica/magnetite systemsin drug controlled release. Journal of Materials Science: Materials in Medicine, Vol. 20, 2009, pp. 507–512.10.1007/s10856-008-3592-1 ↗